Sarcopenia, but Not Visceral Fat Amount, is a Risk Factor of Postoperative Complications After Major Hepatectomy

Overview

Journal Int J Clin Oncol

Specialty Oncology

Date 2015 Sep 5

PMID 26338271

Citations 20

Authors

Takaaki Higashi

Hiromitsu Hayashi

Katsunobu Taki

Keita Sakamoto

Hideyuki Kuroki

Hidetoshi Nitta

Daisuke Hashimoto

Akira Chikamoto

Toru Beppu

Hideo Baba

Affiliations

Soon will be listed here.

Abstract

Background: Major hepatectomy is associated with significant morbidity and mortality rates, particularly in patients aged more than 70 years. This study assessed whether physical indicators, such as sarcopenia and visceral fat amount, could predict morbidity and mortality after major hepatectomy.

Methods: The study enrolled 144 patients who underwent curative major hepatectomy. Skeletal muscle and visceral fat amount at the third lumbar vertebra (L3) in the inferior direction were quantified using enhanced computed tomography scans. The patients were divided into two subgroups, with and without sarcopenia, based on median skeletal muscle mass in men and women (43.2 cm(2)/m(2) in men; 35.3 cm(2)/m(2) in women).

Results: The study included 108 men and 36 women, with median skeletal muscle tissue of 43.2 and 35.3 cm(2)/m(2), respectively. The mortality rate was significantly higher in patients with than without sarcopenia [seven cases (9.7 %), one case (1.4 %), respectively; P = 0.021], whereas liver-related morbidity and mortality rates were similar. In patients aged >70 years, the morbidity, liver dysfunction-related morbidity, and mortality rates were significantly higher in patients with than without sarcopenia (P < 0.05 each). In contrast, surgical outcomes were similar in patients with high and low visceral fat amounts.

Conclusions: Sarcopenia was a risk factor for postoperative complications after major hepatectomy, particularly in elderly patients.

Citing Articles

Effect of Nutritional Index on Lenvatinib Treatment Retention Rates in Unresectable Hepatocellular Carcinoma.

Wakamatsu R, Nakayama M, Wakamatsu A, Yamashita Y, Suto H, Katsuragawa M In Vivo. 2025; 39(2):988-999.

PMID: 40010999 PMC: 11884448. DOI: 10.21873/invivo.13904.

Sarcopenia's Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter Analysis.

Fukuhara S, Kobayashi T, Hamaoka M, Naruhiko H, Oishi K, Namba Y In Vivo. 2024; 38(6):2827-2835.

PMID: 39477404 PMC: 11535901. DOI: 10.21873/invivo.13763.

Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis.

Li X, Huang X, Lei L, Tong S Front Nutr. 2023; 10:1233973.

PMID: 37927508 PMC: 10620805. DOI: 10.3389/fnut.2023.1233973.

Role of Machine Learning-Based CT Body Composition in Risk Prediction and Prognostication: Current State and Future Directions.

Elhakim T, Trinh K, Mansur A, Bridge C, Daye D Diagnostics (Basel). 2023; 13(5).

PMID: 36900112 PMC: 10000509. DOI: 10.3390/diagnostics13050968.

Developing and validating a nomogram based on skeletal muscle index and clinical scoring system for prediction of liver failure after hepatectomy.

Ding C, Jia J, Han L, Zhou W, Liu Z, Bai G Front Oncol. 2023; 13:1036921.

PMID: 36741004 PMC: 9893412. DOI: 10.3389/fonc.2023.1036921.

References

Montano-Loza A, Meza-Junco J, Prado C, Lieffers J, Baracos V, Bain V . Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011; 10(2):166-73, 173.e1. DOI: 10.1016/j.cgh.2011.08.028. View

Gaujoux S, Torres J, Olson S, Winston C, Gonen M, Brennan M . Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2012; 19(9):2908-16. DOI: 10.1245/s10434-012-2301-y. View

Pedersen B, Febbraio M . Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012; 8(8):457-65. DOI: 10.1038/nrendo.2012.49. View

Merkow R, Bilimoria K, McCarter M, Bentrem D . Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009; 208(1):53-61. DOI: 10.1016/j.jamcollsurg.2008.08.032. View

Rahbari N, Garden O, Padbury R, Brooke-Smith M, Crawford M, Adam R . Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011; 149(5):713-24. DOI: 10.1016/j.surg.2010.10.001. View

Saunders J, Rosman A, Neihaus D, Gouge T, Melis M . Safety of hepatic resections in obese veterans. Arch Surg. 2011; 147(4):331-7. DOI: 10.1001/archsurg.2011.1404. View

Reddy S, Barbas A, Turley R, Clark Gamblin T, Geller D, Marsh J . Major liver resection in elderly patients: a multi-institutional analysis. J Am Coll Surg. 2011; 212(5):787-95. DOI: 10.1016/j.jamcollsurg.2010.12.048. View

Nishikawa H, Kimura T, Kita R, Osaki Y . Treatment for hepatocellular carcinoma in elderly patients: a literature review. J Cancer. 2013; 4(8):635-43. PMC: 3805991. DOI: 10.7150/jca.7279. View

Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L . Liver resection of colorectal metastases in elderly patients. Br J Surg. 2010; 97(3):366-76. DOI: 10.1002/bjs.6889. View

10.

Mitsiopoulos N, Baumgartner R, Heymsfield S, Lyons W, Gallagher D, Ross R . Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985). 1998; 85(1):115-22. DOI: 10.1152/jappl.1998.85.1.115. View

11.

Liu L, Chen H, Wang M, Zhao Y, Cai G, Qi X . Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis. PLoS One. 2014; 9(3):e91124. PMC: 3961236. DOI: 10.1371/journal.pone.0091124. View

12.

Ezaki T, Yukaya H, Ogawa Y . Evaluation of hepatic resection for hepatocellular carcinoma in the elderly. Br J Surg. 1987; 74(6):471-3. DOI: 10.1002/bjs.1800740614. View

13.

Paugam-Burtz C, Janny S, Delefosse D, Dahmani S, Dondero F, Mantz J . Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg. 2008; 249(1):124-8. DOI: 10.1097/SLA.0b013e31819279cd. View

14.

Peng P, Van Vledder M, Tsai S, Jong M, Makary M, Ng J . Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford). 2011; 13(7):439-46. PMC: 3133709. DOI: 10.1111/j.1477-2574.2011.00301.x. View

15.

Renehan A, Tyson M, Egger M, Heller R, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612):569-78. DOI: 10.1016/S0140-6736(08)60269-X. View

16.

Aldrighetti L, Arru M, Catena M, Finazzi R, Ferla G . Liver resections in over-75-year-old patients: surgical hazard or current practice?. J Surg Oncol. 2006; 93(3):186-93. DOI: 10.1002/jso.20342. View

17.

Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J . Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003; 90(9):1131-6. DOI: 10.1002/bjs.4202. View

18.

Cecchini S, Cavazzini E, Marchesi F, Sarli L, Roncoroni L . Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2010; 35(2):415-23. DOI: 10.1007/s00268-010-0888-3. View

19.

Mastoraki A, Tsakali A, Papanikolaou I, Danias N, Smyrniotis V, Arkadopoulos N . Outcome following major hepatic resection in the elderly patients. Clin Res Hepatol Gastroenterol. 2014; 38(4):462-6. DOI: 10.1016/j.clinre.2014.01.009. View

20.

Sabel M, Lee J, Cai S, Englesbe M, Holcombe S, Wang S . Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011; 18(13):3579-85. DOI: 10.1245/s10434-011-1976-9. View